Valuation
$1.3M
2025 Revenue
$440K
Funding
$0
Team
4
Founded
2012
How BrainFx grew BrainFx to $440K revenue with a 4 person team in 2025.
BrainFx, Inc. conducts ongoing and cutting-edge research with digital technology to create clinical, digital assessment tools for healthcare professionals to measure the early and subtle effects of brain disorders on a person's ability to function in real life. With early intervention, health professionals can minimize disability, and improve quality of life. Healthcare systems may reduce the associated professional time and associated costs it takes to get similar information traditionally up to 85 percent. The premier offering is BrainFx 360, (90 to 120 minute), a new, comprehensive, standardized, research-based digital assessment tool that is designed to help health professionals measure the functional impact of mild to moderate brain injury or disorder. BrainFx Assessments are designed for those aged 10 and up with, or at risk of: brain injury, stroke, mental illness, aging, dementia, and other neurological / brain disorders and other conditions with cognitive effects. Designed to assist healthcare teams with the information needed for early detection, diagnosis & treatment of neurological dysfunction, and to assist with clinical decision-making for return to activity. Measuring an individual's brain function means healthcare teams will have comprehensive information available quickly (reports available immediately) to consider for treatment planning and recommendations. BrainFx assessments can also provide a baseline, to be compared at a future date so any declines or improvements in functional skills can be tracked. At BrainFx, we want to make the invisible effects of mild to moderate brain disorders visible.
Last updated
BrainFx Revenue
In 2025, BrainFx's revenue reached $440K. Since its launch in 2012, BrainFx has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2025 | BrainFx Hit $440k revenue in December 2025 |
| 2012 | Launched with $0 revenue |
BrainFx Valuation, Funding Rounds
BrainFx's most recent disclosed valuation is $1.3M.
BrainFx is a bootstrapped Neurodiversity Cognitive Assessment Software startup. Founded in 2012, BrainFx has grown to $440K in revenue without raising any venture capital or outside funding.
As a self-funded Neurodiversity Cognitive Assessment Software SaaS company, BrainFx has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
BrainFx Employees & Team Size
BrainFx employs approximately 4 people as of 2026.
BrainFx has 4 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2025 | Reached 4 employees (December 2025) |
Customers
We do not have customer count information for BrainFx yet.
Frequently Asked Questions about BrainFx
What is BrainFx's revenue?
BrainFx generates $440K in revenue.
How much funding does BrainFx have?
BrainFx raised $0.
How many employees does BrainFx have?
BrainFx has 4 employees.
Where is BrainFx headquarters?
BrainFx is headquartered in Pickering, Ontario, Canada.
People Also Viewed

MightyScout
MightyScout helps marketers effortlessly run influencer marketing campaigns with a suite of campaign management, influencer tracking, influencer relationship management, and analytics & reporting tools.

Texperia
Texperia is a SaaS platform that will empower HR to communicate, celebrate, engage and measure using experiential tech.

RTB-Media
RTB-Media is a cross-channel trading desk and reporting platform for brands and agencies.

Collude
Collude is an advanced online communication and mobile networking platform designed to act as a central hub for businesses to bring Moderators, Organisers, Members and Suppliers into a single collaboration platform making big impact to their businesses .

Ubicall
Ubicall is a cloud-based mobile platform that transforms your users customer support experience while reducing your own cost of operations.

Stout Street Capital
Stout Street Capital is an early-stage venture capital fund that seeks to invest in early-stage companies. The firm was founded in 2016 and is based in Denver, Colorado. It seeks to invest in companies operating in the technology, robotics, artificial intelligence, analytics and medical technology sectors.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .
